Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Elizabeth McFarland

Concepts (386)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
50
2026
2981
3.150
 Why?
HIV-1
27
2026
882
2.840
 Why?
Respiratory Syncytial Virus Vaccines
6
2022
38
2.280
 Why?
HIV Antibodies
13
2026
63
2.210
 Why?
Respiratory Syncytial Virus Infections
6
2022
130
2.090
 Why?
Respiratory Syncytial Virus, Human
6
2022
77
2.080
 Why?
Infectious Disease Transmission, Vertical
18
2025
186
2.050
 Why?
Anti-Retroviral Agents
12
2023
240
1.680
 Why?
Anti-HIV Agents
13
2026
853
1.520
 Why?
Viral Proteins
3
2020
368
1.500
 Why?
Antibodies, Neutralizing
9
2026
321
1.100
 Why?
Antibodies, Viral
8
2022
654
1.090
 Why?
Colonography, Computed Tomographic
3
2024
8
0.940
 Why?
Antibodies, Monoclonal
6
2025
1456
0.840
 Why?
AIDS Vaccines
8
2018
53
0.830
 Why?
Pre-Exposure Prophylaxis
1
2025
237
0.770
 Why?
Pregnancy Complications, Infectious
8
2016
408
0.730
 Why?
Gene Deletion
2
2020
384
0.710
 Why?
Breast Feeding
4
2025
441
0.630
 Why?
Atazanavir Sulfate
2
2017
42
0.620
 Why?
HIV Protease Inhibitors
2
2017
67
0.610
 Why?
Ritonavir
2
2017
72
0.600
 Why?
Infant, Newborn
24
2026
6270
0.580
 Why?
HIV Envelope Protein gp120
6
2017
61
0.560
 Why?
Vaccines, Attenuated
6
2022
130
0.560
 Why?
Vaccination
6
2020
1468
0.540
 Why?
Incidental Findings
1
2018
79
0.530
 Why?
Infant
32
2026
9820
0.510
 Why?
Telemedicine
1
2025
893
0.500
 Why?
Radiation Dosage
1
2018
189
0.490
 Why?
Nelfinavir
1
2016
8
0.490
 Why?
Lopinavir
1
2016
28
0.490
 Why?
Syncope
1
2016
58
0.480
 Why?
Bradycardia
1
2016
52
0.480
 Why?
Patient Dropouts
1
2016
65
0.470
 Why?
Lyme Disease
1
2016
56
0.470
 Why?
Health Resources
1
2016
126
0.450
 Why?
Infant, Newborn, Diseases
1
2016
113
0.430
 Why?
HIV
5
2014
248
0.410
 Why?
Patient Compliance
2
2018
607
0.380
 Why?
Humans
76
2026
141284
0.380
 Why?
Immunogenicity, Vaccine
4
2021
34
0.370
 Why?
Child
37
2025
22390
0.370
 Why?
Referral and Consultation
1
2018
802
0.370
 Why?
Female
50
2026
75814
0.360
 Why?
T-Lymphocytes, Cytotoxic
4
2005
173
0.350
 Why?
CD4-Positive T-Lymphocytes
2
2017
1111
0.340
 Why?
Virus Replication
4
2020
533
0.340
 Why?
Adolescent
28
2025
22116
0.330
 Why?
Male
41
2026
70140
0.330
 Why?
Lymphocyte Activation
5
2017
1136
0.300
 Why?
Young Adult
14
2026
13727
0.280
 Why?
HIV Seropositivity
2
2023
119
0.270
 Why?
Viral Load
9
2017
507
0.270
 Why?
Bone Density
2
2025
496
0.260
 Why?
Double-Blind Method
3
2020
1992
0.250
 Why?
RNA, Viral
8
2023
695
0.240
 Why?
Antibodies, Bacterial
2
2018
145
0.240
 Why?
Dyslipidemias
2
2017
177
0.230
 Why?
Antiretroviral Therapy, Highly Active
6
2017
278
0.230
 Why?
Bone Development
1
2025
53
0.230
 Why?
Immunoenzyme Techniques
1
2005
206
0.220
 Why?
Immunoglobulin G
3
2022
882
0.210
 Why?
Diverticulum
1
2024
12
0.210
 Why?
Viremia
3
2011
154
0.210
 Why?
Gene Products, gag
2
1994
38
0.210
 Why?
Mammography
1
2025
157
0.200
 Why?
Child, Preschool
21
2022
11511
0.200
 Why?
Squalene
3
2017
8
0.190
 Why?
Pregnancy
11
2023
7035
0.190
 Why?
Complementarity Determining Regions
1
2002
51
0.190
 Why?
Prospective Studies
5
2025
7805
0.190
 Why?
Drug Resistance, Viral
2
2016
121
0.180
 Why?
CD4 Lymphocyte Count
4
2017
273
0.180
 Why?
Half-Life
1
2021
145
0.180
 Why?
Growth Differentiation Factor 15
1
2021
40
0.180
 Why?
Feasibility Studies
1
2025
1037
0.170
 Why?
Mitochondrial Diseases
1
2021
94
0.170
 Why?
Colorado
4
2025
4599
0.170
 Why?
Immunization Schedule
2
2018
202
0.170
 Why?
Drug Therapy, Combination
4
2017
1043
0.170
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
334
0.170
 Why?
RNA, Small Untranslated
1
2020
12
0.160
 Why?
Fibroblast Growth Factors
1
2021
185
0.160
 Why?
T-Lymphocytes
2
2009
1996
0.160
 Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
16
0.160
 Why?
Pilot Projects
1
2025
1820
0.160
 Why?
Hydrophobic and Hydrophilic Interactions
1
2020
188
0.150
 Why?
Cytokines
2
2021
2079
0.150
 Why?
Point Mutation
1
2020
239
0.150
 Why?
Body Temperature
1
2020
224
0.150
 Why?
Haemophilus Vaccines
2
2018
30
0.140
 Why?
Immunocompromised Host
2
2000
201
0.140
 Why?
Insulin Resistance
3
2019
1221
0.140
 Why?
Immunologic Memory
2
2021
358
0.140
 Why?
Interleukin-12
1
1998
122
0.140
 Why?
Darunavir
1
2017
19
0.140
 Why?
Metabolic Syndrome
1
2021
352
0.140
 Why?
CD8-Positive T-Lymphocytes
2
2011
911
0.130
 Why?
Mycobacterium Infections, Nontuberculous
2
2012
363
0.130
 Why?
Therapeutic Equipoise
1
2017
2
0.130
 Why?
Dose-Response Relationship, Drug
1
2021
2047
0.130
 Why?
Interferon-gamma
5
2012
784
0.130
 Why?
Antibody Formation
1
2018
295
0.130
 Why?
Lymphopoiesis
1
2017
26
0.130
 Why?
Immunoglobulin A
2
2017
214
0.130
 Why?
Uganda
1
2017
86
0.130
 Why?
Receptors, CCR5
1
2017
61
0.130
 Why?
High-Throughput Screening Assays
1
2018
158
0.130
 Why?
CD4-CD8 Ratio
1
2016
24
0.130
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
11
0.130
 Why?
Adult
16
2026
39319
0.120
 Why?
Adoption
1
2016
30
0.120
 Why?
Virus Latency
1
2016
80
0.120
 Why?
Mothers
3
2017
776
0.120
 Why?
Cohort Studies
8
2025
5809
0.120
 Why?
Continuity of Patient Care
1
2018
282
0.110
 Why?
Early Diagnosis
1
2016
243
0.110
 Why?
Chickenpox Vaccine
1
2015
74
0.110
 Why?
Zimbabwe
2
2025
63
0.110
 Why?
Body Height
2
2017
200
0.110
 Why?
Disease Susceptibility
1
2017
351
0.110
 Why?
Gene Products, env
1
1994
6
0.110
 Why?
Haemophilus influenzae type b
1
2014
12
0.110
 Why?
Chickenpox
1
2015
81
0.110
 Why?
Bacterial Capsules
1
2014
31
0.110
 Why?
Antibody Affinity
1
2014
60
0.110
 Why?
Acquired Immunodeficiency Syndrome
2
2000
232
0.110
 Why?
South Africa
2
2025
200
0.110
 Why?
Cote d'Ivoire
2
2025
8
0.110
 Why?
Parotitis
1
2014
6
0.110
 Why?
Vaccines, Synthetic
4
2005
138
0.110
 Why?
Developing Countries
1
2016
308
0.100
 Why?
Cytotoxicity, Immunologic
3
2002
221
0.100
 Why?
Intestines
1
2017
355
0.100
 Why?
Puberty, Delayed
1
2013
9
0.100
 Why?
Leukocytes, Mononuclear
4
2013
571
0.100
 Why?
RNA-Directed DNA Polymerase
1
1993
34
0.100
 Why?
Mycobacterium chelonae
1
1993
9
0.100
 Why?
Vaccines
1
2018
407
0.100
 Why?
Lipids
1
2017
686
0.100
 Why?
Patient Selection
1
2017
685
0.100
 Why?
Retrospective Studies
8
2023
16447
0.100
 Why?
Lamivudine
3
2023
64
0.090
 Why?
Breast Neoplasms
1
2025
2246
0.090
 Why?
Colorectal Neoplasms
1
2020
811
0.090
 Why?
Mitochondria
2
2021
962
0.090
 Why?
Cell Movement
1
2017
962
0.090
 Why?
Cardiovascular Diseases
2
2016
2091
0.090
 Why?
Pediatric Obesity
1
2019
604
0.090
 Why?
Clinical Trials as Topic
1
2017
1035
0.090
 Why?
STAT1 Transcription Factor
1
2012
71
0.090
 Why?
Child Development
1
2017
496
0.090
 Why?
Body Fat Distribution
1
2011
47
0.090
 Why?
Body Weight
2
2017
992
0.090
 Why?
Polysorbates
3
2017
41
0.090
 Why?
Mycobacterium avium Complex
1
2012
87
0.090
 Why?
Epitopes
2
2022
476
0.090
 Why?
Cost-Benefit Analysis
2
2025
612
0.080
 Why?
Research Design
1
2017
1105
0.080
 Why?
United States
9
2023
15298
0.080
 Why?
Biomedical Research
1
2017
684
0.080
 Why?
Interleukin-2
2
2003
448
0.080
 Why?
Respiratory Tract Infections
1
2014
388
0.080
 Why?
Exercise
1
2021
2113
0.080
 Why?
Prenatal Exposure Delayed Effects
1
2016
656
0.070
 Why?
Freezing
1
2009
88
0.070
 Why?
Absorptiometry, Photon
2
2025
266
0.070
 Why?
Blood
1
2009
110
0.070
 Why?
Algorithms
1
2016
1764
0.070
 Why?
Phenotype
1
2017
3172
0.070
 Why?
Staff Development
1
2009
60
0.070
 Why?
Age Factors
4
2019
3295
0.070
 Why?
T-Lymphocyte Subsets
2
2002
413
0.070
 Why?
Biomarkers
4
2021
4180
0.070
 Why?
Lymphocyte Subsets
2
2009
87
0.070
 Why?
Enzyme-Linked Immunosorbent Assay
2
2021
849
0.070
 Why?
Longitudinal Studies
3
2025
2929
0.070
 Why?
Specimen Handling
1
2009
180
0.070
 Why?
Enterovirus A, Human
1
2007
13
0.070
 Why?
Faculty
1
2009
153
0.070
 Why?
Withholding Treatment
1
2008
76
0.070
 Why?
Adipose Tissue
1
2011
645
0.060
 Why?
Central Nervous System Viral Diseases
1
2007
77
0.060
 Why?
Polymerase Chain Reaction
4
2011
1050
0.060
 Why?
DNA, Viral
2
2000
363
0.060
 Why?
Academic Medical Centers
1
2009
523
0.060
 Why?
Flow Cytometry
3
2009
1182
0.060
 Why?
False Negative Reactions
1
2025
60
0.060
 Why?
Enterovirus Infections
1
2007
172
0.060
 Why?
Cell Line
3
2012
2863
0.060
 Why?
Isoantigens
1
1984
17
0.060
 Why?
C-Reactive Protein
2
2021
416
0.060
 Why?
Medical Audit
1
2025
77
0.060
 Why?
Immunity, Cellular
1
2006
266
0.050
 Why?
Linear Models
2
2020
855
0.050
 Why?
Disease Outbreaks
1
2007
424
0.050
 Why?
Follow-Up Studies
3
2021
5222
0.050
 Why?
Confusion
1
2024
31
0.050
 Why?
Sequence Analysis, DNA
2
2007
815
0.050
 Why?
Comorbidity
2
2021
1671
0.050
 Why?
Thymus Gland
1
1984
316
0.050
 Why?
Tablets
1
2023
42
0.050
 Why?
Constriction, Pathologic
1
2024
242
0.050
 Why?
Regression Analysis
2
2021
1013
0.050
 Why?
Risk Factors
4
2021
10490
0.050
 Why?
Respiratory Syncytial Viruses
1
2022
58
0.050
 Why?
Genes, T-Cell Receptor beta
1
2002
23
0.050
 Why?
Immunophenotyping
2
1994
325
0.050
 Why?
Zidovudine
2
2015
77
0.050
 Why?
Clone Cells
1
2002
267
0.050
 Why?
Dose-Response Relationship, Immunologic
1
2001
77
0.040
 Why?
Triazoles
1
2023
163
0.040
 Why?
Cough
1
2022
133
0.040
 Why?
Vaccines, Subunit
1
2001
50
0.040
 Why?
Emtricitabine
1
2023
204
0.040
 Why?
Pyridones
1
2023
191
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2021
51
0.040
 Why?
Tenofovir
1
2023
288
0.040
 Why?
Lung
1
2014
4051
0.040
 Why?
Ganciclovir
1
2000
53
0.040
 Why?
Public Health Surveillance
1
2021
83
0.040
 Why?
Computer Simulation
1
2005
1009
0.040
 Why?
Africa
1
2020
113
0.040
 Why?
Adjuvants, Immunologic
2
2017
238
0.040
 Why?
Injections, Subcutaneous
1
2020
164
0.040
 Why?
Diagnostic Tests, Routine
1
2021
110
0.040
 Why?
Sex Factors
2
2019
2055
0.040
 Why?
Symptom Assessment
1
2021
132
0.040
 Why?
Cross-Sectional Studies
3
2021
5653
0.040
 Why?
HIV Seronegativity
1
2019
30
0.040
 Why?
HLA-D Antigens
1
1999
30
0.040
 Why?
Risk
1
2021
903
0.040
 Why?
Case-Control Studies
2
2019
3577
0.040
 Why?
Cytomegalovirus Infections
1
2000
197
0.040
 Why?
Prevalence
2
2016
2795
0.040
 Why?
Cholesterol, HDL
1
2019
196
0.040
 Why?
Lymphocyte Culture Test, Mixed
1
1998
51
0.040
 Why?
Cytotoxicity Tests, Immunologic
1
1998
37
0.040
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
27
0.040
 Why?
Vaccines, Combined
1
2018
49
0.040
 Why?
Hospitals
1
2023
688
0.040
 Why?
Poliovirus Vaccine, Inactivated
1
2018
28
0.040
 Why?
Amino Acid Sequence
1
2002
2146
0.040
 Why?
Odds Ratio
1
2021
1057
0.040
 Why?
Hepatitis B Vaccines
1
2018
43
0.040
 Why?
Mutation
3
2018
4006
0.030
 Why?
Drug Resistance, Microbial
2
2000
67
0.030
 Why?
Molecular Sequence Data
1
2002
2911
0.030
 Why?
Colon
1
2020
295
0.030
 Why?
Nutrition Surveys
1
2019
280
0.030
 Why?
Case Management
1
2018
65
0.030
 Why?
Antigens, Viral
1
1998
179
0.030
 Why?
Cholesterol
1
2019
404
0.030
 Why?
Cholesterol, LDL
1
2019
360
0.030
 Why?
Epitopes, T-Lymphocyte
1
1998
181
0.030
 Why?
Immune Tolerance
1
1999
373
0.030
 Why?
Triglycerides
1
2019
510
0.030
 Why?
Treatment Adherence and Compliance
1
2017
27
0.030
 Why?
Reproducibility of Results
1
2005
3345
0.030
 Why?
Disease Management
1
2021
634
0.030
 Why?
Lymphocyte Count
2
2009
167
0.030
 Why?
Cell Division
1
1998
792
0.030
 Why?
Uncertainty
1
2017
137
0.030
 Why?
Treatment Failure
1
2017
355
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Multicenter Studies as Topic
1
2017
367
0.030
 Why?
Seroepidemiologic Studies
1
2015
170
0.030
 Why?
Patient Outcome Assessment
1
2016
132
0.030
 Why?
Genes, pol
1
1994
7
0.030
 Why?
Time-to-Treatment
1
2017
224
0.030
 Why?
Malnutrition
1
2016
84
0.030
 Why?
Maternal Exposure
1
2017
201
0.030
 Why?
Coinfection
1
2016
131
0.030
 Why?
Antiviral Agents
1
2000
748
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1610
0.030
 Why?
Vaccines, Conjugate
1
2014
63
0.030
 Why?
Counseling
1
2018
395
0.030
 Why?
Neutropenia
1
2015
151
0.030
 Why?
Treatment Outcome
2
2021
11216
0.030
 Why?
Cells, Cultured
2
2008
4149
0.030
 Why?
Sexual and Gender Minorities
1
2018
236
0.030
 Why?
Global Health
1
2017
384
0.030
 Why?
Anemia
1
2015
175
0.030
 Why?
Maternal-Fetal Exchange
1
2014
170
0.030
 Why?
Electron Transport Complex IV
1
2013
61
0.030
 Why?
Electron Transport Complex I
1
2013
42
0.020
 Why?
Tuberculosis, Cutaneous
1
1993
3
0.020
 Why?
Thrombocytopenia
1
2015
206
0.020
 Why?
HIV Reverse Transcriptase
1
1993
31
0.020
 Why?
CD8 Antigens
1
1993
75
0.020
 Why?
Medication Adherence
1
2017
510
0.020
 Why?
Radiography, Thoracic
1
2014
179
0.020
 Why?
Severity of Illness Index
1
2021
2904
0.020
 Why?
CD3 Complex
1
1993
106
0.020
 Why?
Drug Administration Schedule
2
2008
771
0.020
 Why?
Blood Pressure
1
2019
1740
0.020
 Why?
Oxidative Phosphorylation
1
2013
204
0.020
 Why?
Lymphocytes
1
1994
390
0.020
 Why?
DNA, Mitochondrial
1
2013
209
0.020
 Why?
P-Selectin
1
2011
28
0.020
 Why?
E-Selectin
1
2011
57
0.020
 Why?
Heteroduplex Analysis
1
2011
1
0.020
 Why?
Tuberculosis, Pulmonary
1
1993
129
0.020
 Why?
Pandemics
1
2020
1655
0.020
 Why?
Antigens, CD
1
1994
537
0.020
 Why?
Chemokine CCL2
1
2011
115
0.020
 Why?
Blood Transfusion
1
1994
395
0.020
 Why?
Hyperlipidemias
1
2011
126
0.020
 Why?
Hospitalization
1
2021
2264
0.020
 Why?
Cell Proliferation
2
2009
2502
0.020
 Why?
Protein Multimerization
1
2012
194
0.020
 Why?
Interferon-alpha
1
2012
195
0.020
 Why?
Nontuberculous Mycobacteria
1
1993
205
0.020
 Why?
Fibrinogen
1
2011
179
0.020
 Why?
Cell Adhesion Molecules
1
2011
179
0.020
 Why?
Healthcare Disparities
1
2017
674
0.020
 Why?
Cross Infection
1
1993
259
0.020
 Why?
Infant, Premature
1
1994
599
0.020
 Why?
Diagnosis, Differential
1
2014
1491
0.020
 Why?
Pokeweed Mitogens
1
2009
7
0.020
 Why?
L-Selectin
1
2009
24
0.020
 Why?
Human Experimentation
1
2009
13
0.020
 Why?
Tetanus
1
2009
27
0.020
 Why?
Leukocyte Common Antigens
1
2009
88
0.020
 Why?
Candida
1
2009
41
0.020
 Why?
Obesity
1
2021
3007
0.020
 Why?
Multivariate Analysis
1
2011
1505
0.020
 Why?
Meningitis, Aseptic
1
2007
13
0.020
 Why?
Virus Cultivation
1
2007
31
0.020
 Why?
Phosphorylation
1
2012
1753
0.020
 Why?
Interleukin-6
1
2011
775
0.020
 Why?
Cerebrospinal Fluid
1
2007
91
0.020
 Why?
Data Interpretation, Statistical
1
2009
374
0.020
 Why?
Paralysis
1
2007
70
0.020
 Why?
Pregnancy Outcome
1
2010
453
0.020
 Why?
Multiple Organ Failure
1
2007
127
0.020
 Why?
B-Lymphocytes
1
2012
857
0.020
 Why?
Kinetics
1
2010
1620
0.020
 Why?
Genotype
1
2011
1854
0.020
 Why?
Respiratory System
1
2007
155
0.020
 Why?
Immunoglobulin A, Secretory
1
2005
9
0.020
 Why?
Phosphates
1
1987
178
0.010
 Why?
Cell Survival
1
2009
1123
0.010
 Why?
Muscles
1
1987
331
0.010
 Why?
Encephalitis
1
2007
137
0.010
 Why?
Gastrointestinal Tract
1
2007
196
0.010
 Why?
Mucous Membrane
1
2005
127
0.010
 Why?
Chemistry, Physical
1
1984
37
0.010
 Why?
Antigen-Antibody Reactions
1
1984
50
0.010
 Why?
Chemical Phenomena
1
1984
80
0.010
 Why?
DNA-Binding Proteins
1
2012
1483
0.010
 Why?
Myasthenia Gravis
1
1984
23
0.010
 Why?
Immunologic Deficiency Syndromes
1
1984
71
0.010
 Why?
Saliva
1
2005
246
0.010
 Why?
Tissue Distribution
1
1984
325
0.010
 Why?
Tomography, X-Ray Computed
1
2014
2765
0.010
 Why?
Epithelium
1
1984
311
0.010
 Why?
Aging
2
2003
1919
0.010
 Why?
Blood Glucose
1
2013
2286
0.010
 Why?
Body Mass Index
1
2011
2390
0.010
 Why?
Infusions, Intravenous
1
2003
418
0.010
 Why?
Middle Aged
2
2020
34658
0.010
 Why?
Anti-Bacterial Agents
1
1993
1866
0.010
 Why?
Reference Values
1
2003
803
0.010
 Why?
Mice, Inbred BALB C
1
1984
1261
0.010
 Why?
Suspensions
1
2000
29
0.010
 Why?
Capsules
1
2000
40
0.010
 Why?
Urban Population
1
2003
482
0.010
 Why?
Drug Tolerance
1
2000
105
0.010
 Why?
Cytomegalovirus
1
2000
163
0.010
 Why?
Signal Transduction
1
2012
5116
0.010
 Why?
Epithelial Cells
1
1984
1105
0.010
 Why?
Administration, Oral
1
2000
825
0.010
 Why?
Immunization
1
2000
402
0.010
 Why?
Time Factors
1
2008
6951
0.010
 Why?
Macrophages
1
1984
1478
0.010
 Why?
Recombinant Proteins
1
2000
1362
0.010
 Why?
Tail
1
1987
29
0.000
 Why?
Mice
1
1984
17969
0.000
 Why?
Phosphocreatine
1
1987
44
0.000
 Why?
Salamandridae
1
1987
33
0.000
 Why?
Animals
2
1987
37328
0.000
 Why?
Aged
1
1984
24836
0.000
 Why?
Adenosine Triphosphate
1
1987
484
0.000
 Why?
Magnetic Resonance Spectroscopy
1
1987
614
0.000
 Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (386) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)